• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 144-158 of 456 results

1018 Exhibit: Nalox1018 APTAR Press Release

Document IPR2019-00699, No. 1018-18 Exhibit - Nalox1018 APTAR Press Release (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1027 Exhibit: Nalox1027 Dowling 2008

Document IPR2019-00699, No. 1027-27 Exhibit - Nalox1027 Dowling 2008 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1049 Exhibit: Nalox1049 Role of Naloxone Full Transcript

Document IPR2019-00699, No. 1049-48 Exhibit - Nalox1049 Role of Naloxone Full Transcript (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1039 Exhibit: Nalox1039 Merck Index

Document IPR2019-00699, No. 1039-38 Exhibit - Nalox1039 Merck Index (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1060 Exhibit: Nalox1060 Loimer 1994

Document IPR2019-00699, No. 1060-58 Exhibit - Nalox1060 Loimer 1994 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1014 Exhibit: Nalox1014 US Patent No 5,866,154 Bahal

Document IPR2019-00699, No. 1014-14 Exhibit - Nalox1014 US Patent No 5,866,154 Bahal (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1008 Exhibit: Nalox1008 Chinese Patent No 1,575,795 Wang

Document IPR2019-00699, No. 1008-8 Exhibit - Nalox1008 Chinese Patent No 1,575,795 Wang (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1028 Exhibit: Nalox1028 2002 FDA Guidance

Document IPR2019-00699, No. 1028-28 Exhibit - Nalox1028 2002 FDA Guidance (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1065 Exhibit: Nalox1065 Wisconsin Affidavit Part 1 of 2

Document IPR2019-00699, No. 1065-62 Exhibit - Nalox1065 Wisconsin Affidavit Part 1 of 2 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1003 Exhibit: Nalox1003 Hochhaus Declaration 699

Document IPR2019-00699, No. 1003-3 Exhibit - Nalox1003 Hochhaus Declaration 699 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1043 Exhibit: Nalox1043 Lemke 2008

Document IPR2019-00699, No. 1043-42 Exhibit - Nalox1043 Lemke 2008 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1029 Exhibit: Nalox1029 2003 FDA Guidance

Document IPR2019-00699, No. 1029-29 Exhibit - Nalox1029 2003 FDA Guidance (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1012 Exhibit: Nalox1012 Handbook of Pharmaceutical Excipients

Document IPR2019-00699, No. 1012-12 Exhibit - Nalox1012 Handbook of Pharmaceutical Excipients (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1037 Exhibit: Nalox1037 Kleiman Wexler 1989

Document IPR2019-00699, No. 1037-36 Exhibit - Nalox1037 Kleiman Wexler 1989 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze

1023 Exhibit: Nalox1023 Boyer 2012

Document IPR2019-00699, No. 1023-23 Exhibit - Nalox1023 Boyer 2012 (P.T.A.B. Feb. 19, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 10 11 12 13 14 ... >>